Status:
RECRUITING
Periinterventional Coagulation Management of Patients Undergoing a TIPS
Lead Sponsor:
Medical University of Graz
Conditions:
Liver Cirrhosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Assess whether a pre-interventional thrombelastography guided algorithm for assessing and correction of coagulation status in cirrhotic patients is safe and effective
Detailed Description
Transjugular intrahepatic portosystemic shunt (TIPS) is a very effective procedure to treat complications of portal hypertension in liver cirrhosis. TIPS implantation is indicated in cirrhotic patient...
Eligibility Criteria
Inclusion
- inclusion criteria
- Liver cirrhosis
- \>18 years
- Indication for TIPS implantation
- Ability to sign informed consent exclusion criteria
- Contraindications against TIPS implantation
- Hepatocellular carcinoma BCLC D
- Ongoing bleeding
- pre-existing anticoagulant therapy at time of inclusion
- administration of blood products within 1 week prior to the enrolment
- Other malignancies that lead to an impaired 90-day survival
- Inherit blood clotting disorders
- Hepatic encephalopathy grade 3 or 4
- any other condition or circumstance, which, in the opinion of the investigator, would affect the patient's ability to participate in the protocol
Exclusion
Key Trial Info
Start Date :
May 27 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2027
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT04421924
Start Date
May 27 2020
End Date
May 1 2027
Last Update
December 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Internal Medicine, Medical University of Graz
Graz, Austria, 8010